Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.
Financial Results:
Solara Active Pharma Sciences Ltd reported Revenues for Q1FY26 of ₹319.00 Crores down from ₹363.00 Crore year on year, a fall of 12.12%.
Total Expenses for Q1FY26 of ₹310.00 Crores down from ₹378.00 Crores year on year, a fall of 17.99%.
Consolidated Net Profit of ₹11.00 Crores from -₹13.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹2.91, from -₹3.74 in the same quarter of the previous year.